Item 2.02. Results of Operations and Financial Condition

On February 2, 2023, Quest Diagnostics Incorporated (the "Company") issued a press release announcing, among other things, its results for the quarter and full year ended December 31, 2022. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 8.01. Other Events

On February 2, 2023, the Company issued a press release announcing that the Company's Board of Directors authorized the Company to repurchase an additional $1 billion of the Company's common stock as part of the Company's common stock repurchase program and increased the quarterly dividend from $0.66 to $0.71 per share. The 7.6% increase in the quarterly dividend is the Company's twelfth since 2011 and is effective with the dividend payable on April 24, 2023 to shareholders of record of the Company's common stock on April 10, 2023. A copy of the press release is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits



d.       Exhibit

           99.1       Press release of Quest Diagnostics Incorporated dated February 2, 2023,
                    announcing, among other things, its results for the quarter and full year ended
                    December 31, 2022.

           99.2       Press release of Quest Diagnostics Incorporated dated February 2, 2023,
                    announcing the increase in its quarterly dividend and the increase in its share
                    repurchase authorization.

           104      The cover page from this current report on Form 8-K, formatted in Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses